1. Homepage
  2. Equities
  3. United Kingdom
  4. London Stock Exchange
  5. E-therapeutics plc
  6. News
  7. Most relevant
    ETX   GB00B2823H99

E-THERAPEUTICS PLC

(ETX)
  Report
Delayed London Stock Exchange  -  05/20 11:35:09 am EDT
19.48 GBX   -3.11%
05/04Earnings Flash (ETX.L) E-THERAPEUTICS Posts FY22 Revenue GBP477,000
MT
05/04Earnings Flash (ETX.L) E-THERAPEUTICS Posts FY22 Loss GBX-1.65
MT
05/04E-therapeutics plc Announces Change of Registered Office
CI
SummaryQuotesChartsNewsCalendarCompanyFinancials 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news
Most relevant news about E-THERAPEUTICS PLC
05/04Earnings Flash (ETX.L) E-THERAPEUTICS Posts FY22 Revenue GBP477,000
MT
05/04Earnings Flash (ETX.L) E-THERAPEUTICS Posts FY22 Loss GBX-1.65
MT
05/04E-therapeutics plc Announces Change of Registered Office
CI
05/04E-therapeutics plc Reports Earnings Results for the Full Year Ended January 31, 2022
CI
04/12E-therapeutics Achieves Key Milestones Under Collaboration with Galapagos
MT
04/05E-therapeutics Jumps 8% on Collaboration to Develop New Immuno-Oncology Therapies
MT
2021E-Therapeutics CFO to Step Down; Interim Finance Chief Named
MT
2021E-Therapeutics plc Announces Executive Changes
CI
2021Director Dealing – 26th October 2021
PU
2021E THERAPEUTICS : Interim Results, July 2021 and RNAi Platform Development Presentation
PU
2021E THERAPEUTICS : Interim results for six months ended 31 July 2021
PU
2021E THERAPEUTICS : Earnings Flash (ETX.L) E-THERAPEUTICS Reports Fiscal H1 Loss GBX-0.54
MT
2021E THERAPEUTICS : Earnings Flash (ETX.L) E-THERAPEUTICS Reports Fiscal H1 Revenue GBP477,00..
MT
2021E THERAPEUTICS : RNAi Platform Characterisation Results
PU
2021E-therapeutics plc Reports Earnings Results for the Half Year Ended July 31, 2021
CI
2021E-therapeutics plc Announces the Results of the RNAi Platform Characterization Studies
CI
2021E THERAPEUTICS : Files New Patents To Protect RNAi Platform Tech
MT
2021E THERAPEUTICS : Notice of Interim Results 2021
PU
2021E THERAPEUTICS : Patent Filings – October 2021
PU
2021E-therapeutics plc Announces Patent Filing Applications
CI
2021E THERAPEUTICS : To Start Trading On US OTCQX Best Market
MT
2021E THERAPEUTICS : Commencement of trading on the OTCQX Best Market in the United States
PU
2021E THERAPEUTICS : Director Dealing and Issue of Equity
PU
2021E THERAPEUTICS : Further milestone in Galapagos collaboration
PU
2021E THERAPEUTICS : 2021 AGM Proxy Results
PU
2021E THERAPEUTICS : Senior Management Appointment and Grant of Options
PU
2021E-therapeutics plc Appoints Alison Gallafent as Head of Intellectual Property for the C..
CI
2021E THERAPEUTICS : Notice of Annual General Meeting and Posting of Annual Report and Account..
PU
2021E THERAPEUTICS : Annual Report for the year ended 31 January 2021
PU
2021E THERAPEUTICS : Final Results for the Year Ended 31 January 2021
PU
2021E THERAPEUTICS : Earnings Flash (ETX.L) E-THERAPEUTICS Posts FY21 Loss GBX-0.99
MT
2021E THERAPEUTICS : Earnings Flash (ETX.L) E-THERAPEUTICS Posts FY21 Revenue GBP317,000
MT
2021E-Therapeutics plc Reports Earnings Results for the Full Year Ended January 31, 2021
CI
2021e-Therapeutics Expects to Receive Payments From Galapagos
DJ
2021E THERAPEUTICS : to receive two key milestone payments from Galapagos
PU
2021E THERAPEUTICS : Appointment of Chief Financial Officer
PU
2021E THERAPEUTICS : Names CFO
MT
2021E-therapeutics plc Announces the Appointment of Karl Keegan as Chief Financial Officer
CI
2021E THERAPEUTICS : Appoints New Nonexecutive Chairman
MT
2021E-Therapeutics plc Announces Board Changes
CI
2021E THERAPEUTICS : RNA Therapeutics Platform Announced
PU
2021E-Therapeutics plc Announces Addition of its RNAi Platform as a Therapeutic Drug Modali..
CI
2020E THERAPEUTICS : COVID-19 Project Update
PU
2020E THERAPEUTICS : Rises 10% on Positive Compound Testing Results to Treat COVID-19
MT
2020E-therapeutics plc Announces Results of Experimental Testing on the Compounds for the T..
CI
2020E-therapeutics plc Announces Appointment of Ali Mortazavi as CEO
CI
2020E-Therapeutics plc Reports Earnings Results for the Half Year Ended July 31, 2020
CI
2020E-therapeutics plc Announces Executive Changes
CI
2020E-therapeutics plc Appoints Paul Burke as Chair of the Scientific Advisory Board
CI
2020E-therapeutics plc Announces Expansion into RNA interference
CI
2020E-Therapeutics plc Announces the Appointment of Laura Roca-Alonso as Chief Business Off..
CI
2020E-Therapeutics plc Reports Earnings Results for the Full Year Ended January 31, 2020
CI
2020E THERAPEUTICS : Board Changes and Placing
PU
2020E-therapeutics plc Announces Management Changes
CI
2019E-Therapeutics plc Reports Earnings Results for the Half Year Ended July 31, 2019
CI
2019E-Therapeutics Enters into Agreement with Five Pharma Company for Neurodegenerative Dis..
CI
2019Suspended Woodford fund has sold around £100 million of assets
RE
2019E-Therapeutics Plc. Reports Earnings Results for the Full Year Ended January 31, 2019
CI
2018E THERAPEUTICS : Research Collaboration Agreement with Novo Nordisk
PU
2018E THERAPEUTICS : and C4X Collaboration
PU
2018C4X Discovery Holdings PLC and e-therapeutics plc Announce an Update on Their Collabora..
CI
2018E THERAPEUTICS : Drug Discovery Innovation Programme Presentation
PU
2018E THERAPEUTICS : Interim Results for six months ended 31 July 2018
PU
2018E-Therapeutics plc Announces Consolidated Unaudited Earnings Results for Six Months End..
CI
2018E THERAPEUTICS : Notice of Interim Results
PU
2018E THERAPEUTICS : Director Shareholding
PU
2018E THERAPEUTICS : Collaboration with C4X Discovery Holdings PLC
PU
2018E-Therapeutics plc Enters into Collaboration Agreement with C4X Discovery Holdings plc
CI
2018E-THERAPEUTICS PLC : Full Year Results
BU
2018E-Therapeutics plc Reports Consolidated Earnings Results for the Year Ended January 31,..
CI
2018E THERAPEUTICS : Director/PDMR Shareholding
PU
2018E THERAPEUTICS : enters two AI collaborations
PU
2017E THERAPEUTICS : Director/PDMR Shareholding
PU
2017E THERAPEUTICS : Appointment of Director
PU
2017E-Therapeutics plc Announces Board Changes
CI
1  2  3  4Next
Upcoming event on E-THERAPEUTICS PLC